Notably, treatment with 3 mg/kg of BAY-876, a GLUT1 inhibitor that mimics glucose starvation, produced similar anti-tumor effects, suggesting a potential link between CASC8 and glucose metabolism in vivo (P < 0.001). The gene discussed is CASC8; the disease is neoplasm.